Markets

A new GMO IPO: Bioceres files for an $81 million US IPO

A generic image of a person holding a pen and paper
Credit: Shutterstock photo

Bioceres, an Argentinian developer of crop productivity traits for genetically modified seeds, filed on Thursday with the SEC to raise up to $81 million in an initial public offering.

Bioceres has partnered with Arcadia Biosciences ( RKDA ), Dow ( DOW ) and Verdeca to develop a soybean that demonstrates high tolerance to drought and salinity.

The Rosario, Argentina-based company, which was founded in 2002 and booked $11 million in sales for the 12 months ended June 30, 2015, plans to list on the NYSE under the symbol BIOX. Bioceres initially filed confidentially on May 20, 2015. Piper Jaffray and Itau BBA are the joint bookrunners on the deal. No pricing terms were disclosed.

The article A new GMO IPO: Bioceres files for an $81 million US IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO) or the Global IPO Fund (symbol: IPOSX) , may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

RKDA

Other Topics

IPOs

Latest Markets Videos